Your email has been successfully added to our mailing list.

×
0 0 -0.00599999999999993 -0.0166666666666666 -0.0266666666666667 -0.0334 -0.0399333333333332 -0.0566666666666666
Stock impact report

UPDATE 2-Correvio slumps after FDA staffers say benefits of heart drug do not outweigh risks [Yahoo! Finance News]

CORREVIO PHARMA CORP ORDINARY SHARES (CORV) 
Last correvio pharma corp ordinary shares earnings: 11/14 07:00 am Check Earnings Report
UPDATE 2-Correvio slumps after FDA staffers say benefits of heart drug do not outweigh risks ds analyst comments; Updates shares) By Saumya Joseph Dec 6 Reuters) - U.S. Food and Drug ministration staffers reviewing Correvio Pharma Corp's heart drug said on Friday they did not believe the benefits of the therapy outweighed its risks, sending the company's shares down nearly 38%. The drug, Brinavess, approved in Europe and other countries including Canada, aims to correct erratic heart rhythm in the upper heart chambers due to a condition known as atrial fibrillation or AFib. Although Correvio has provided evidence of benefits, Brinavess comes with "serious liabilities" including low blood pressure, irregular heartbeats in the lower heart chambers, and death, the FDA staffers said in documents released on Friday. https://bit.ly/2LvQSSl) They also said the risk and management data provided by Correvio did not provide reassurance about the safe use of Brinavess. A panel of independent exp Show less Read more
Impact Snapshot
Event Time:
CORV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CORV alerts
Opt-in for
CORV alerts

from News Quantified
Opt-in for
CORV alerts

from News Quantified